Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Virios Therapeutics Inc
(NQ:
VIRI
)
0.3514
-0.0346 (-8.96%)
Streaming Delayed Price
Updated: 3:59 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Virios Therapeutics Inc
< Previous
1
2
3
4
5
6
Next >
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 20, 2022
Via
Benzinga
Why Virios Therapeutics Is Trading Lower By 75%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session
September 20, 2022
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 51% to $0.4957. Crown ElectroKinetics, last month, posted a Q4 net loss of $4.5 million.
Via
Benzinga
Nasdaq Down 50 Points; Crude Oil Falls Sharply
September 20, 2022
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 50 points on Tuesday.
Via
Benzinga
Virios Therapeutics Shares Tank After Failing Fibromyalgia Study
September 19, 2022
Via
Benzinga
Earnings Scheduled For August 11, 2022
August 11, 2022
Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
September 20, 2022
On Tuesday, 507 stocks hit new 52-week lows.
Via
Benzinga
Why Virios Therapeutics Shares Are Getting Hammered
September 20, 2022
Virios Therapeutics Inc (NASDAQ: VIRI) shares are trading lower by 74.50% to $0.51 Tuesday morning after the company priced a 10 million share public offering at $0.50 per share. Also, HC Wainwright &...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2022
September 20, 2022
Upgrades
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 20, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
September 20, 2022
Good morning, investor! It's time to start the day with a breakdown of the biggest pre-market stock movers for Tuesday morning!
Via
InvestorPlace
Why O2Micro International Is Trading Higher By 7%; Here Are 25 Stocks Moving Premarket
September 20, 2022
Gainers
Via
Benzinga
Why KnowBe4 Shares Jumped Over 28%; Here Are 79 Biggest Movers From Yesterday
September 20, 2022
Gainers Ventoux CCM Acquisition Corp. (NASDAQ: VTAQ) shares jumped 54.6% to settle at $7.05 on Monday.
Via
Benzinga
Virios Therapeutics, Inc. Announces Pricing of Public Offering
September 19, 2022
From
Virios Therapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
September 19, 2022
Gainers Reshape Lifesciences (NASDAQ:RSLS) stock increased by 10.1% to $0.39 during Monday's after-market session. The company's market cap stands at $1.3 million.
Via
Benzinga
Virios Therapeutics, Inc. Announces Proposed Public Offering
September 19, 2022
From
Virios Therapeutics, Inc.
Via
Business Wire
US Markets Turn Higher As Dow Jumps Over 100 Points
September 19, 2022
U.S. stocks traded higher in volatile trading toward the end of trading, with the Dow Jones gaining more than 100 points on Monday.
Via
Benzinga
Dow, S&P 500 Drop In Volatile Trading Ahead Of Fed's Rate Decision
September 19, 2022
U.S. stocks traded lower in volatile trading toward the end of trading, with the Dow Jones dropping around 40 points on Monday.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
September 19, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
September 19, 2022
On Monday, 429 stocks made new 52-week lows.
Via
Benzinga
Why Virios Therapeutics Is Trading Lower By Over 71%, Here Are 55 Stocks Moving In Monday's Mid-Day Session
September 19, 2022
Gainers MicroCloud Hologram Inc. (NASDAQ: HOLO) shares jumped 134.6% to $19.74.
Via
Benzinga
Analyzing Virios Therapeutics's Short Interest
September 19, 2022
Virios Therapeutics's (NASDAQ:VIRI) short percent of float has risen 6.58% since its last report. The company recently reported that it has 53 thousand shares sold short, which is...
Via
Benzinga
Why Is Virios Therapeutics (VIRI) Stock Down 71% Today?
September 19, 2022
Virios Therapeutics (VIRI) stock is falling hard on Monday after revealing results from its Phase 2b Study of IMC-1 in Fibromyalgia.
Via
InvestorPlace
US Stocks Open Lower; Housing Market Index Drops In September
September 19, 2022
U.S. stocks traded lower this morning, after recording losses in the previous week.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 19, 2022
Via
Benzinga
Virios Therapeutics Announces Top-Line Results from Phase 2b Study of IMC-1 in Fibromyalgia
September 19, 2022
From
Virios Therapeutics, Inc. (VIRI)
Via
Business Wire
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 15, 2022
Via
Benzinga
This Technology Stock Jumped 55% Following Q2 Results; Here Are 96 Biggest Movers From Yesterday
August 17, 2022
Gainers Eargo, Inc. (NASDAQ: EAR) jumped 77.2% to close at $2.02. The FDA finalized rule enabling access to over-the-counter hearing aids.
Via
Benzinga
Virios Therapeutics Commences Mid-Stage Long-COVID Study
August 15, 2022
Virios Therapeutics (Nasdaq: VIRI) has initiated patient dosing in its exploratory Long-COVID trial evaluating IMC-2 (valacyclovir + celecoxib).
Via
Benzinga
Virios Therapeutics’ Announces Dosing of First Patient in IMC-2 Long-COVID Treatment Trial
August 15, 2022
From
Virios Therapeutics, Inc. (VIRI)
Via
Business Wire
Virios Therapeutics Announces Second Quarter 2022 Financial Results and Provides Corporate Update
August 11, 2022
From
Virios Therapeutics, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.